Virtual Coaching Helps Weight Loss Drug Users Keep Muscle

Weight Loss Drug Users Keep Muscle better when a virtual care team walks alongside them, a new peer-reviewed study suggests. Adults taking GLP-1 medicines who joined a coaching program with built-in exercise support lost more weight and more body fat than people receiving usual care — and held onto more of their muscle in the process.

The finding, published in the journal Diabetes, Obesity and Metabolism, lands at a moment when weight-loss injections have gone mainstream and doctors are increasingly warning that rapid shedding can take muscle with it. According to the researchers, lean tissue can account for nearly a third of the weight people lose on these medicines. Losing it matters: less muscle can drag down resting metabolic rate, sap everyday physical function, and make regained weight more likely, while raising longer-term risks of frailty and bone loss.

The study, announced Tuesday by Omada Health, followed 245 adults with obesity who had started a GLP-1 medicine within the previous eight weeks. About 151 of them enrolled in the company's virtual GLP-1 Care Track, while 94 received usual care, which could mean medication alone or some other non-Omada lifestyle program. More than a quarter of the usual-care group said they were already using another wellness program during the study, so the comparison was not simply coaching versus nothing.

What changed after twelve weeks

By the end of the study period, the gap between the two groups was clear on nearly every measure, according to the announcement. The coaching group lost 6.0 percent of their starting body weight, compared with 3.3 percent for usual care. They also trimmed their body-fat percentage by roughly twice as much, while their share of muscle ticked up slightly more, rising 0.6 points against 0.2 for the comparison group.

The differences went beyond the scale. Participants with coaching support reported greater gains in well-being, physical functioning, and confidence in their ability to keep losing weight. Symptoms of depression and anxiety fell by roughly 30 percent, a significantly larger drop than in the usual-care group. That mental-health signal matters because weight-loss drugs can be an isolating experience: side effects, food noise, and body-image shifts arrive fast, often between doctor visits.

The program itself was deliberately hands-on. Members worked with a dedicated health coach, joined peer support groups specific to GLP-1 treatment, and used digital tools for meal logging and behavior tracking, plus AI-powered nutrition guidance. An exercise specialist built each participant a personalized activity plan designed by a physical therapist. Body composition was tracked at home with bioelectrical impedance scales — a practical choice for a virtual study, though not the gold-standard lab measurement.

The fine print: what the study can't prove

"GLP-1 care is about more than how much weight you lose. It's about the quality of the weight loss, as losing too much muscle can make it harder to keep the weight off long-term," said Thomas Tsang, chief medical officer at Omada, in the announcement. "Too many people are left to manage side effects, exercise, and nutrition on their own once GLP-1 treatment starts."

Still, there are reasons to read the results carefully. The research was funded by the company behind the program and announced in a company release, which calls for independent replication. Twelve weeks is a short window for a treatment people may take for years, and the study did not track whether the muscle advantage — or the weight loss — survives after the coaching ends. Home impedance scales can also be thrown off by hydration and meal timing, adding noise to the body-composition numbers.

Even with those caveats, the direction of travel is hard to ignore. Weight Loss Drug Users Keep Muscle best when exercise and nutrition support are built into treatment rather than bolted on afterward, the researchers argue — and the data suggest virtual programs can deliver that support at scale. The findings will be presented in detail Tuesday afternoon at a major obesity research conference in Boston, where clinicians are debating exactly this question: how to make sure the weight coming off is the right kind.

For anyone on these medicines, the takeaway is practical rather than dramatic. A prescription handles appetite; it does not handle protein intake, resistance training, or the mental grind of changing how you eat. The study suggests that gap is where coaching earns its keep — and that closing it may be the difference between losing weight and losing the muscle you need to keep it off. Related reading: our earlier coverage of how diet quality connects to mood, why grocery labels can mislead, and new findings on hormone therapy and migraines.